Nirmatrelvir/ritonavir (Paxlovid) reduces hospitalization, mortality in patients 65+ with COVID-19; effect on younger patients unclear
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Nirmatrelvir/ritonavir (Paxlovid) Reduces Hospitalization, Mortality in Patients 65+ With COVID-19; Effect On Younger Patients Unclear." EE+ POEM Archive, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315730/all/Nirmatrelvir_ritonavir__Paxlovid__reduces_hospitalization__mortality_in_patients_65+_with_COVID_19.
Nirmatrelvir/ritonavir (Paxlovid) reduces hospitalization, mortality in patients 65+ with COVID-19; effect on younger patients unclear. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315730/all/Nirmatrelvir_ritonavir__Paxlovid__reduces_hospitalization__mortality_in_patients_65+_with_COVID_19. Accessed February 9, 2025.
Nirmatrelvir/ritonavir (Paxlovid) reduces hospitalization, mortality in patients 65+ with COVID-19; effect on younger patients unclear. (2025). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315730/all/Nirmatrelvir_ritonavir__Paxlovid__reduces_hospitalization__mortality_in_patients_65+_with_COVID_19
Nirmatrelvir/ritonavir (Paxlovid) Reduces Hospitalization, Mortality in Patients 65+ With COVID-19; Effect On Younger Patients Unclear [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2025. [cited 2025 February 09]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315730/all/Nirmatrelvir_ritonavir__Paxlovid__reduces_hospitalization__mortality_in_patients_65+_with_COVID_19.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Nirmatrelvir/ritonavir (Paxlovid) reduces hospitalization, mortality in patients 65+ with COVID-19; effect on younger patients unclear
ID - 1315730
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315730/all/Nirmatrelvir_ritonavir__Paxlovid__reduces_hospitalization__mortality_in_patients_65+_with_COVID_19
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -